Incorporate the latest clinical trial data, real-world evidence, and clinical practice guidelines to accurately differentiate, diagnose, and manage MPNs and SM. Evaluate the mechanisms of action and safety and efficacy of targeted therapies for the treatment of MPNs and SM. Differentiate SM variants and identify genetic mutations driving targeted treatment algorithms. Implement strategies to optimize therapeutic selection and/or identify clinical trial opportunities that may be appropriate for patients with MPNs or SM. Recognize and appropriately manage TRAEs to optimize patient outcomes and improve QoL. Utilize a multidisciplinary approach to implement appropriate personalized, patient-centered strategies to care for patients with MPNs and SM.
- Provider:HMP Education
- Activity Link: https://hmpeducation.com/program/24onccme106.2
- Start Date: 2025-01-06 06:00:00
- End Date: 2025-01-06 06:00:00
- Credit Details: AAPA Category 1 Credit™️: 2.5 hours
AMA PRA Category 1 Credit™️: 2.5 hours
Nursing: 2.5 hours
Pharmacy: 2.5 hours - MOC Credit Details: ABS - 2.5 Point; Credit Type(s): Accredited CME (ABS)
ABIM - 2.5 Point; Credit Type(s): Medical Knowledge (ABIM) - Commercial Support: Source: Blueprint Medicines Corporation - Amount: 0 - Is Kind Support: False Source: CTI BioPharma Corp. a Sobi Company - Amount: 0 - Is Kind Support: False Source: Incyte Corporation - Amount: 0 - Is Kind Support: False Source: PharmaEssentia Corporation - Amount: 0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: General Surgery, Internal Medicine